The property in which 2 drugs with equivalent active ingredients (as a brand name drug and its common equivalent) or 2 separate dosage forms (in tablets and oral suspension) of the same drug have identical bioavailability and generate a similar impact on the physiological activity site. Innovations are a new idea, a new device or a new process. Developments are the utilization of better arrangements that meet new prerequisites, incoherent needs or existing business sector needs. He is competent through more efficient products, processes, services, technologies or new ideas that are readily available to markets, governments and society. Innovations are something original and new, as important innovations that "penetrate" the market or society. The impact factor of the bioequivalence review is mainly calculated on the basis of the number of articles submitted to a blind peer review by the competent editorial board in order to guarantee excellence, the essence of work and the number of citations received for the same articles published.
Commentary: Journal of Formulation Science & Bioavailability
Commentary: Journal of Formulation Science & Bioavailability
Review Article: Journal of Formulation Science & Bioavailability
Review Article: Journal of Formulation Science & Bioavailability
Short Communication: Journal of Formulation Science & Bioavailability
Short Communication: Journal of Formulation Science & Bioavailability
Review Article: Journal of Formulation Science & Bioavailability
Review Article: Journal of Formulation Science & Bioavailability
Research Article: Journal of Formulation Science & Bioavailability
Research Article: Journal of Formulation Science & Bioavailability
Research Article: Journal of Formulation Science & Bioavailability
Research Article: Journal of Formulation Science & Bioavailability
Keynote: Pharmacoeconomics: Open Access
Keynote: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report